Loading
Loading
Vertex Pharmaceuticals INC / MA ceo salary
Reshma Kewalramani, CEO and President of VERTEX PHARMACEUTICALS INC / MA (VRTX), received $21,144,261 ($21.1M) in total compensation for FY2025, up 2.7% from the prior year. Stock awards of $15,002,270 were the largest component. Figures come from VERTEX PHARMACEUTICALS INC / MA's DEF 14A filed 2 Apr 2026 (accession 0000875320-26-000153).
Reported total from the latest DEF 14A pay table. Source filing (accession 0000875320-26-000153). These figures come from VERTEX PHARMACEUTICALS INC / MA's DEF 14A filed 2 Apr 2026 (accession 0000875320-26-000153).
| Component | Amount |
|---|---|
| Salary | $1,600,000 |
| Stock awards | $15,002,270 |
| Cash incentive | $4,118,640 |
| Other | $423,351 |
| Total | $21,144,261 |
FAQ
See also: VRTX ticker page